CLOs on the Move

Betsy Johnson Regional Hospital

www.bjrh.org

 
Betsy Johnson Regional Hospital is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Betsy Johnson Regional Hospital is based in Dunn, NC. You can find more information on Betsy Johnson Regional Hospital at www.bjrh.org
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details

Similar Companies

North Mississippi Primary Health Care

North Mississippi Primary Health Care is a community health center operating in Northeast Mississippi for the past 25 years. They provide healthcare services to Benton, Marshall, Tippah, Prentiss, Union, Alcorn, and Tishomingo counties.

Dailey Resources

Dailey Resources Ltd is a Scranton, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Rehabilitation Institute of Southern California

RIO attains its goal of improving the quality of life of disabled persons by providing comprehensive, coordinated programs which increase the ability of disabled individuals to function at home and at school, on the job, and in the community. RIO was established in 1950 to serve the multi-faceted needs of persons with functional disabilities caused by birth defects, medical condition or accidents. Services are provided without regard to age, race, creed, sexual orientation, and gender.

Micro Invasive Technology

Micro Invasive Technology is a Pomfret Center, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Repertoire

Repertoire Immune Medicines is working to unleash the remarkable power of the human immune system to prevent, treat or cure cancer, autoimmune conditions, and infectious diseases. Repertoire scientists created and developed a suite of technologies for its DECODE discovery and DEPLOY product platforms that allow in-depth characterization of the immune synapse and the ability to rationally design, and clinically develop, multi-clonal immune medicines. The company is currently conducting experimental medicine clinical trials using autologous T cells primed against cancer antigens and tethered to IL-15.